Chief Scientific Officer John Renger sold $1.6M of Cerevel Therapeutics Holdings, Inc.

Sold$1,559,093

$34.65Price

45,000Shares

−96%Stake

What CERE did after the filing

Prices for CERE after this filing aren't in yet.

Traded Wed, Apr 13. Filed Fri, Apr 15, 12:19 PM ET, during the session. Not investment advice.